Basal CORT level at sacrifice showed a trend to be increased in the CSDS groups ( Figure S2B ), with no significant differences between genotypes.
← all phrases
“showed a trend”
In the literature
The DBC@L group, which was only crosslinked with L, showed a trend toward increased epithelial thickness compared to the DBC group, although this difference was not statistically significant ( Fig. 7 E).
The LD group showed a trend toward higher risk of oxygenator changes, although this did not reach statistical significance (RR, 1.54; 95% CI, 0.94-2.53; I 2 = 42%; Figure 3 C).
HR/β1 insertion and multiple insertions showed a trend toward being risk factors for EFS.
The DM group showed a trend towards increased fibrosis, whereas the DM_CKD group exhibited significantly greater fibrosis than WT controls, as shown by PR staining (Fig. 9 ).
The SFI results showed a trend of recovery in all three groups.
Notably, this reduction showed a trend toward normalization after treatment.
The immunoglobulin plus corticosteroid combination showed a trend of providing the longest treatment duration at 10 months among patients with refractory CIDP in LOT1.
With regard to papillary growth, PWSH showed a trend towards higher proportions of papillary components and were significantly more likely to exhibit papillary predominance.
Patients who achieved pathological complete response (pCR) after neoadjuvant therapy showed a trend toward improved survival, though not statistically significant HR = 0.83 (95% CI: 0.48–1.41, p = 0.483).
Interestingly, VLDL and total cholesterol levels showed a trend of decrease at 2 weeks post-injection, but then stabilized and returned to similar levels by 4 weeks post-injection.
Although the difference was not statistically significant ( p = 0.164), the CGF-PTa group showed a trend toward higher fusion grades.
The resilience level of Qinghai Province showed a trend of ‘decrease-then-increase’.
Although plasma GFAP levels showed a trend toward improved classification of disease severity, the difference compared with plasma NfL levels did not reach statistical significance (p = 0.55).
No significant differences in clinical severity were observed across serotypes, although DENV‐2 showed a trend toward lower platelet counts.
The deconvolution of immune cells showed a trend of an uncontrolled pro-inflammatory state and poor immune function in higher disease severities.
Notably, the ALNM− PBC subpopulation showed a trend toward ALNM+ PBC (Fig. 4 I and J), suggesting that it may represent a transitional or precursor population actively transiting toward the more aggressive phenotype.
Conversely, patients with a history of seizures that impaired consciousness showed a trend toward smaller thickness/volume increases than those with consciousness-sparing focal seizures.
Luminex analysis of BALF cytokines showed that IFN-γ, IL-1β and RANTES levels were significantly increased, and MCP-1 showed a trend toward an increase, in PBS-exposed ablated mice compared with PBS-exposed control mice ( Fig.
Post hoc comparisons showed a trend toward a smaller CPS at 1 day post-training for both groups (active a-tDCS, from 1.23 ± 0.12 to 1.14 ± 0.13 logMAR; sham a-tDCS, from 1.44 ± 0.13 to 1.35 ± 0.12 logMAR; P = 0.06).
In contrast, DEGs enriched in the “oxidative phosphorylation”321 pathway showed a trend of being mostly upregulated in Prmt5 AKO , including Cox8b and Cox7a1 ( Figure 5B , Table S7 ).
Notably, RNA electrophoresis of the LNP samples on day 12 showed a trend of increase in percentages of intact mRNA for the LNPs with 4.7% DOTAP.
However, longer two‐year survival only showed a trend toward improvement in LMWH‐treated GB patients.
Both fahd‐1(syb5439) and fahd‐1(tm5005) strains showed a trend toward reduced motility, although the high standard deviation within the N2 group prevented determination of statistical significance.
In both subtypes, sevoflurane showed a trend in decreasing steady‐state current amplitudes, with a stronger suppression from −67 to −47 mV (Figure 6C–E ).